Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
N/A
-529,226 Closed
0 $0
Q1 2021

May 14, 2021

SELL
N/A
-288,558 Reduced 35.29%
529,226 $5.68 Million
Q4 2020

Feb 12, 2021

BUY
N/A
369,735 Added 82.52%
817,784 $12 Million
Q1 2020

May 14, 2020

BUY
N/A
1,950 Added 0.44%
448,049 $1.81 Million
Q4 2018

Feb 13, 2019

SELL
N/A
-22,300 Reduced 4.76%
446,099 $763,000
Q1 2018

May 14, 2018

BUY
N/A
18,399 Added 4.09%
468,399 $3.37 Million
Q4 2017

Feb 14, 2018

SELL
N/A
-50,000 Reduced 10.0%
450,000 $3.29 Million
Q2 2017

Aug 14, 2017

BUY
N/A
500,000
500,000 $1.98 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.